Lindsey Roeker, M.D., is a board-certified hematologist / oncologist and clinical researcher focusing on chronic lymphocytic leukemia (CLL) and Richter’s transformation. Dr. Roeker is deeply committed to partnering with her patients through their cancer journeys while providing high-quality, personalized care.

Dr. Roeker hails from Wisconsin, attended medical school at Mayo Clinic School of Medicine, and completed Internal Medicine Residency at Brigham and Women’s Hospital/Harvard Medical School. She was a hematology and medical oncology fellow and chief fellow at Memorial Sloan Kettering Cancer Center. Dr. Roeker has since focused on delivering cutting-edge care to her patients with CLL, Richter's transformation, and lymphoproliferative disorders. Her research interests include development of new medications and personalized approaches to treatment, as well as collaboration with translational scientists to uncover drug resistance mechanisms and immune repertoire perturbations that predict toxicity and response to CLL-directed therapy.